Biogen And Eisai To Present ADUHELM Data At Alzheimer’s Association International Conference 2021
Item-level analysis from EMERGE trial shows consistency in slowing decline across cognitive, functional and behavioral measures in early Alzheimer's disease
Presentations include an assessment of the